Elephas Biosciences Announces New Research Partnership with the University of Louisville to Study Advanced Stage Solid Cancer Tumors in Colorectal, Liver and Pancreatic Cancers

MADISON, Wis., February 24, 2026 – Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today a new research partnership with the University of Louisville that will evaluate the impact of a combination therapy of surgical intervention and immunotherapy in three different cancers, including colorectal, liver, and pancreatic. As part of the collaboration, the University of Louisville will be analyzing live tumor specimens on the Elephas Live Platform in conjunction with multiple Investi